- Home
- NAMS vs MDA Comparison
NAMS vs MDA Comparison
Compare NAMS & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$30.14
N/A
Current Price
$32.39
Company Overview
Basic Information| Metric | NAMS | MDA |
|---|---|---|
| Founded | 2019 | 1969 |
| Country | Netherlands | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | N/A | 2026 |
Fundamental Metrics
Financial Performance| Metric | NAMS | MDA |
|---|---|---|
| Price | $30.14 | $32.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $46.75 | N/A |
| AVG Volume (30 Days) | ★ 865.3K | 825.7K |
| Earning Date | 05-07-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.64 | $9.54 |
| Revenue Next Year | $530.85 | $13.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.06 | $30.35 |
| 52 Week High | $42.00 | $33.75 |
Technical Indicators
Market Signals| Indicator | NAMS | MDA |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 58.61 |
| Support Level | $29.73 | N/A |
| Resistance Level | $31.72 | N/A |
| Average True Range (ATR) | 1.62 | 1.79 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 50.55 | 57.51 |
Price Performance
Historical Comparison NAMS
MDA
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.